Horizon Pharma (HZNP) Posts Narrwer than Expected Q1 Loss of 85c/Share

Horizon Pharma (NASDAQ: HZNP) reported Q1 EPS of ($0.85), $0.07 better than the analyst estimate of ($0.92). Revenue for the quarter came in at $2.7 million versus the consensus estimate of $3.69 million.

For earnings history and earnings-related data on Horizon Pharma (HZNP) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
• Veritone (VERI) Misses Q2 EPS by 13c ; Offers Guidance
• Elutia Inc. (ELUT) Misses Q2 EPS by 2c